Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017 Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …
News
astrazeneca_logo_building

AstraZeneca continues pivot to east with Chinese collaboration

November 27, 2017 Medical Communications, Sales and Marketing AstraZeneca, biotech, drugs, pharma, pharmaceutical

It’s been a rocky year for AstraZeneca, it has scored some major successes yet its year has been marred by …
News
shutterstock_138095450

Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals

November 27, 2017 Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …
News
houses-of-parliament-1055056_960_720

UK government unveils pharma research HQ coup

November 27, 2017 Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical

The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …
News
640px-hiv-budding-color

Learning lessons from HIV to change the treatment access landscape

November 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma

Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …
Feature
88

Tesaro secures EU approval in specific ovarian cancer population

November 23, 2017 Sales and Marketing Europe, European Commission, Tesaro, Zejula, pharma

The European Commission has granted Tesaro’s Zejula (niraparib) marketing approval in Europe, it has emerged.  Zejula is a poly (ADP-ribose) …
News
online_survey_icon_or_logo_v2

Collaboration in Biopharma

November 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …
News
gsk_boronia_australia

FDA approves first-ever two-drug HIV regimen, GSK’s Juluca

November 22, 2017 Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
News
addict-2713526_960_720

EU approves opioid treatment, amid fears of US-like crisis

November 22, 2017 Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical

The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
News
promotional_banner

Free Webinar: The End Game – Payer Engagement

November 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
News
shutterstock_273326141

Partnerships hold the key to making HIV history

November 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Janssen, pharma

Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be …
Feature
acorda-therapeutics-inc-logo

Acorda scraps Parkinson’s drug after five trial deaths

November 20, 2017 Research and Development, Sales and Marketing Acorda therapeutics, Parkinson's, patient deaths, pharma

Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …
News
shutterstock_95714119

Children are still prescribed codeine despite FDA warnings, study finds

November 20, 2017 Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …
News

Roche unveils strong combination treatment data in lung cancer

November 20, 2017 Research and Development, Sales and Marketing Cancer, NSCLC< lung cancer, Roche, avastin, immunotherapy, pharma, tecentriq

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026